Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTO: Olanzapine in Cancer Cachexia
NCT05705492Phase 2Recruiting
- Sponsor
- OHSU Knight Cancer Institute
- Start
- Jul 2024
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olanzapine in cancer cachexia, sponsored by OHSU Knight Cancer Institute. Started Jul 2024; status: recruiting.
02
Drugs
olanzapine
03
Conditions
cancer cachexia
Beyond the preview
Go deeper on NCT05705492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05705492.